The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
July 7th 2025
Y-90 resin microspheres offer a new option for liver cancer patients for the treatment of unresectable hepatocellular carcinoma.
Study: AI May Help Predict Responses to Systemic Therapies in Non-Small Cell Lung Cancer
March 26th 2020A study published in Clinical Cancer Research has shown that using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC) can predict tumor sensitivity to 3 systematic cancer therapies by using artificial intelligence (AI).
Read More
Ensuring a Welcoming Facility Is Vital to Maintaining the Health of LGBTQ Patients with Cancer
March 12th 2020Lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce the gaps in care.
Read More
Triple-Negative Breast Cancer: Improved Outcomes and Providing Patient-Centered Care
March 3rd 2020Melissa B. Armitage, PharmD, BCOP, a clinical pharmacist who works in breast oncology at the Moffitt Cancer Center in Tampa, Florida, discussed this disease's pathophysiology, natural progression, and risk factors.
Read More